Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer

  • J. Gaulin Service d'hémato-oncologie; CHU de Sherbrooke
  • R. Kotb Service d'hémato-oncologie; CHU de Sherbrooke
  • E. Turcotte Departement de médecine nucléaire; CHu de Sherbrooke
  • G. Bérard Depatement de la pharmacie; CHU de Sherbrooke
  • G. Schmutz Service de radiologie; CHU de Sherbrooke
  • B. Sawan Depatement de Pathologie; CHU de Sherbrooke
  • P. Beauregard Service d'hémato-oncologie; CHU de Sherbrooke
How to Cite
Gaulin, J., Kotb, R., Turcotte, E., Bérard, G., Schmutz, G., Sawan, B., & Beauregard, P. (1). Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer. Current Oncology, 16(5), 84-86. https://doi.org/10.3747/co.v16i5.395
Section
Case Report